Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

Pancreatic neuroendocrine neoplasms (PanNENs) are rare tumours that compose 1–2% of all pancreatic tumours. Patients with metastatic grade 3 neoplasia are usually treated with chemotherapy but have a poor progression-free and overall survival. According to the WHO 2017 classification, they are divid...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Abir Salwa, Perren, Aurel, Lindskog, Cecilia, Welin, Staffan, Sorbye, Halfdan, Grönberg, Malin, Janson, Eva Tiensuu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327066/
https://www.ncbi.nlm.nih.gov/pubmed/32606315
http://dx.doi.org/10.1038/s41598-020-67670-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327066/
https://www.ncbi.nlm.nih.gov/pubmed/32606315
http://dx.doi.org/10.1038/s41598-020-67670-7

Ejemplares similares